Eris Lifesciences Ltd redeemed 43,750 8% Secured Unlisted Redeemable Non-Convertible Debentures worth Rs 437.50 crore due as of February 21, 2025, in line with its obligations from the Swiss Parenteral acquisition on February 13, 2024.
AI Assistant
ERIS Lifesciences Ltd
2025
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.